Physician profile
Arthur Belanger
NPI 1083949077
$2,639.31
in general payments reported to CMS, 2019-2025
25 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.54 · 2020: $53.49 · 2021: $1,388 · 2022: $136 · 2023: $346 · 2024: $262 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $1,200.00 | 2021 | |
| Globus Medical, INC. | $266.58 | 2025 | Senza, Omnia |
| Paratek Pharmaceuticals, INC. | $204.31 | 2023-2025 | Nuzyra |
| Horizon Therapeutics Plc | $197.43 | 2019-2023 | Krystexxa |
| Stryker Corporation | $153.69 | 2022-2024 | Augment Injectable, Citrefix, Easyfuse |
| Abbvie INC. | $69.70 | 2021-2025 | Vraylar |
| Inspire Medical Systems, INC. | $60.49 | 2024-2025 | Inspire |
| Djo, LLC | $53.51 | 2024 | Cmf |
| Novo Nordisk INC | $52.00 | 2021-2025 | Wegovy |
| Amgen INC. | $43.07 | 2022-2025 | Krystexxa |
| Medartis INC. | $40.97 | 2019-2020 | |
| Dexcom, INC. | $40.22 | 2024 | Dexcom G6 Transmitter |
| Pacira Therapeutics, INC. | $34.64 | 2021 | |
| Convatec INC. | $33.04 | 2021 | |
| Depuy Synthes Sales INC. | $29.69 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $26.40 | 2021-2023 | Senza |
| Alkermes, INC. | $21.72 | 2023 | Lybalvi |
| Organogenesis INC. | $20.72 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.48 | 2021 | |
| Medtronic, INC. | $14.35 | 2025 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $13.69 | 2021 | |
| Pharmacosmos Therapeutics INC. | $12.83 | 2021 | |
| Merck Sharp & Dohme LLC | $12.15 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.61 | 2021 | |
| Bioventus LLC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Belanger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.